Potential Predictive Biomarkers of Clinical Benefit from Emunkitug (HFB200301) in Combination withTislelizumab: Integrated Analysis of Tumor, Peripheral Blood, and Patient Treatment History

Potential Predictive Biomarkers of Clinical Benefit from Emunkitug (HFB200301) in Combination withTislelizumab: Integrated Analysis of Tumor, Peripheral Blood, and Patient Treatment History